Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Killer immunoglobulin-like receptors.

Lorenzo Moretta1, Alessandro Moretta

  • 1Istituto Giannina Gaslini, L.go G. Gaslini, 5-16147 Genova-Quarto, Italy. lorenzomoretta@ospedale-gaslini.ge.it

Current Opinion in Immunology
|September 3, 2004
PubMed
Summary

Killer Ig-like receptors (KIRs) on immune cells block NK cell activation when binding to HLA class I. This interaction is crucial for immune defense and has therapeutic potential in bone marrow transplants for leukemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HCMV-controlling NKG2C<sup>+</sup> NK cells originate from novel circulating inflammatory precursors.

The Journal of allergy and clinical immunology·2021
Same author

Phenotypic and Functional Characterization of NK Cells in αβT-Cell and B-Cell Depleted Haplo-HSCT to Cure Pediatric Patients with Acute Leukemia.

Cancers·2020
Same author

NK Cell Precursors in Human Bone Marrow in Health and Inflammation.

Frontiers in immunology·2019
Same author

Different Features of Tumor-Associated NK Cells in Patients With Low-Grade or High-Grade Peritoneal Carcinomatosis.

Frontiers in immunology·2019
Same author

HO-1 downregulation favors BRAF<sup>V600</sup> melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition.

International journal of cancer·2019
Same author

An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More.

Frontiers in immunology·2019

Area of Science:

  • Immunology
  • Genetics
  • Cell Biology

Background:

  • Killer Ig-like receptors (KIRs) are inhibitory receptors on NK cells and T lymphocytes.
  • KIRs bind to human leukocyte antigen (HLA) class I molecules, preventing NK cell activation.
  • Cells lacking HLA class I are targeted by NK cells, suggesting a role in pathogen and tumor defense.

Purpose of the Study:

  • To explore the evolutionary and genetic diversity of KIR-encoding genes.
  • To understand the regulatory mechanisms of KIR gene expression.
  • To investigate the therapeutic application of KIR-HLA interactions in allogeneic bone marrow transplantation for leukemia.

Main Methods:

  • Analysis of KIR gene evolution and diversification in primates and humans.
  • Investigation of KIR sequence polymorphism and haplotype variation.
  • Study of DNA methylation in regulating KIR gene expression.
  • Exploitation of HLA class I-regulated NK cell function in a bone marrow transplantation model.

Main Results:

  • KIR-encoding genes show rapid evolution and diversification.
  • KIR sequences are highly polymorphic with variable haplotype gene content.
  • DNA methylation regulates KIR gene expression.
  • HLA class I-regulated NK cell function can be used to eradicate acute myeloid leukemias in allogeneic bone marrow transplantation.

Conclusions:

  • KIRs play a critical role in immune surveillance by regulating NK cell activity.
  • The high polymorphism of KIR genes contributes to diverse immune responses.
  • Targeting KIR-HLA interactions offers a promising strategy for leukemia treatment via bone marrow transplantation.

Related Experiment Videos